Skip to main content
Fig. 1 | BMC Infectious Diseases

Fig. 1

From: HIV-1 CRF01_AE subtype and HIV-1 DNA level among patients with chronic HIV-1 infection: a correlation study

Fig. 1

Dynamic changes of clinical parameters during 96 weeks of ART between CRF01_AE and non-CRF01_AE group. a. HIV-1 viral load of both groups was controlled efficiently. b. Increased CD4+ T cell count after ART in both of the two groups. c. The HIV-1 DNA level of CRF01_AE is higher than that of non-CRF01_AE group through all the treatment period. d. The decay of HIV-1 DNA level at baseline and week 96. e. The distribution of individuals classified by HIV-1 DNA level at week 96 (High: HIV-1 DNA level ≥ 3 log10 copies/106 PBMCs; Moderate: HIV-1 DNA level between 2 and 3 log10 copies/106 PBMCs; Low: HIV-1 DNA level ≤ 2 log10 copies/106 PBMCs)

Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us